Jennison Associates’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$30.9M Buy
1,658,942
+181,834
+12% +$3.39M 0.02% 279
2025
Q1
$28.3M Buy
1,477,108
+10,753
+0.7% +$206K 0.02% 287
2024
Q4
$52.8M Sell
1,466,355
-315,648
-18% -$11.4M 0.03% 221
2024
Q3
$75.6M Sell
1,782,003
-187,623
-10% -$7.96M 0.05% 161
2024
Q2
$79.4M Sell
1,969,626
-586,498
-23% -$23.6M 0.05% 148
2024
Q1
$90.5M Buy
2,556,124
+1,265,534
+98% +$44.8M 0.06% 129
2023
Q4
$38.2M Buy
1,290,590
+167,675
+15% +$4.96M 0.03% 239
2023
Q3
$23.3M Buy
1,122,915
+804,488
+253% +$16.7M 0.02% 294
2023
Q2
$7.81M Buy
+318,427
New +$7.81M 0.01% 395
2022
Q1
Sell
-277,581
Closed -$41.8M 705
2021
Q4
$41.8M Sell
277,581
-283,302
-51% -$42.6M 0.03% 255
2021
Q3
$67M Buy
560,883
+27,914
+5% +$3.33M 0.04% 168
2021
Q2
$51.9M Buy
532,969
+16,035
+3% +$1.56M 0.03% 217
2021
Q1
$45.6M Sell
516,934
-29,642
-5% -$2.62M 0.03% 231
2020
Q4
$52.3M Sell
546,576
-17,891
-3% -$1.71M 0.04% 200
2020
Q3
$64.1M Buy
564,467
+104,601
+23% +$11.9M 0.05% 144
2020
Q2
$45.5M Sell
459,866
-177,271
-28% -$17.5M 0.04% 177
2020
Q1
$41M Buy
637,137
+132,532
+26% +$8.53M 0.05% 165
2019
Q4
$30.1M Buy
+504,605
New +$30.1M 0.03% 256
2016
Q3
Sell
-3,703
Closed -$279K 676
2016
Q2
$279K Buy
3,703
+614
+20% +$46.3K ﹤0.01% 610
2016
Q1
$269K Buy
3,089
+102
+3% +$8.88K ﹤0.01% 595
2015
Q4
$353K Buy
+2,987
New +$353K ﹤0.01% 631
2015
Q1
Sell
-69,997
Closed -$8.89M 739
2014
Q4
$8.89M Sell
69,997
-57,207
-45% -$7.27M 0.01% 488
2014
Q3
$17.1M Buy
127,204
+5,268
+4% +$707K 0.02% 446
2014
Q2
$19.8M Buy
121,936
+17,689
+17% +$2.88M 0.02% 426
2014
Q1
$23M Buy
104,247
+9,805
+10% +$2.17M 0.02% 427
2013
Q4
$24.3M Buy
+94,442
New +$24.3M 0.02% 425